Somatic growth and the risks of bronchopulmonary dysplasia and pulmonary hypertension

Connecting epidemiology and physiology 1

Research output: Contribution to journalReview article

Abstract

In the premature infant, poor growth in utero (fetal growth restriction) and in the first weeks of life (postnatal growth restriction) are associated with increased risk for bronchopulmonary dysplasia and pulmonary hypertension. In this review, we summarize the epidemiologic data supporting these associations, present a novel rodent model of postnatal growth restriction, and review 5 promising mechanisms by which poor nutrition may affect the developing lung. These observations support the hypothesis that nutritional and (or) pharmacologic interventions early in life may be able to decrease risk of the pulmonary complications of extreme prematurity.

Original languageEnglish (US)
Pages (from-to)197-205
Number of pages9
JournalCanadian Journal of Physiology and Pharmacology
Volume97
Issue number3
DOIs
StatePublished - Jan 1 2019

Fingerprint

Bronchopulmonary Dysplasia
Pulmonary Hypertension
Epidemiology
Growth
Lung
Nutritional Support
Fetal Development
Premature Infants
Rodentia

Keywords

  • Bronchopulmonary dysplasia
  • Dyslipidemia
  • Fetal growth restriction
  • Inflammation
  • Microbiota
  • mTOR
  • Nutrition
  • Postnatal growth restriction
  • Premature infant
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

@article{f5133adfc6224296849082091c1f15b8,
title = "Somatic growth and the risks of bronchopulmonary dysplasia and pulmonary hypertension: Connecting epidemiology and physiology 1",
abstract = "In the premature infant, poor growth in utero (fetal growth restriction) and in the first weeks of life (postnatal growth restriction) are associated with increased risk for bronchopulmonary dysplasia and pulmonary hypertension. In this review, we summarize the epidemiologic data supporting these associations, present a novel rodent model of postnatal growth restriction, and review 5 promising mechanisms by which poor nutrition may affect the developing lung. These observations support the hypothesis that nutritional and (or) pharmacologic interventions early in life may be able to decrease risk of the pulmonary complications of extreme prematurity.",
keywords = "Bronchopulmonary dysplasia, Dyslipidemia, Fetal growth restriction, Inflammation, Microbiota, mTOR, Nutrition, Postnatal growth restriction, Premature infant, Pulmonary hypertension",
author = "Mark Underwood and Stephen Wedgwood and Satyanarayana Lakshminrusimha and Steinhorn, {Robin H}",
year = "2019",
month = "1",
day = "1",
doi = "10.1139/cjpp-2018-0386",
language = "English (US)",
volume = "97",
pages = "197--205",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "3",

}

TY - JOUR

T1 - Somatic growth and the risks of bronchopulmonary dysplasia and pulmonary hypertension

T2 - Connecting epidemiology and physiology 1

AU - Underwood, Mark

AU - Wedgwood, Stephen

AU - Lakshminrusimha, Satyanarayana

AU - Steinhorn, Robin H

PY - 2019/1/1

Y1 - 2019/1/1

N2 - In the premature infant, poor growth in utero (fetal growth restriction) and in the first weeks of life (postnatal growth restriction) are associated with increased risk for bronchopulmonary dysplasia and pulmonary hypertension. In this review, we summarize the epidemiologic data supporting these associations, present a novel rodent model of postnatal growth restriction, and review 5 promising mechanisms by which poor nutrition may affect the developing lung. These observations support the hypothesis that nutritional and (or) pharmacologic interventions early in life may be able to decrease risk of the pulmonary complications of extreme prematurity.

AB - In the premature infant, poor growth in utero (fetal growth restriction) and in the first weeks of life (postnatal growth restriction) are associated with increased risk for bronchopulmonary dysplasia and pulmonary hypertension. In this review, we summarize the epidemiologic data supporting these associations, present a novel rodent model of postnatal growth restriction, and review 5 promising mechanisms by which poor nutrition may affect the developing lung. These observations support the hypothesis that nutritional and (or) pharmacologic interventions early in life may be able to decrease risk of the pulmonary complications of extreme prematurity.

KW - Bronchopulmonary dysplasia

KW - Dyslipidemia

KW - Fetal growth restriction

KW - Inflammation

KW - Microbiota

KW - mTOR

KW - Nutrition

KW - Postnatal growth restriction

KW - Premature infant

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=85062426989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062426989&partnerID=8YFLogxK

U2 - 10.1139/cjpp-2018-0386

DO - 10.1139/cjpp-2018-0386

M3 - Review article

VL - 97

SP - 197

EP - 205

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 3

ER -